We previously reported an approximate 70% reduction in transmission of endemic MRSA clones following introduction of chlorhexidine-based universal decolonization into the intensive care unit (ICU) at Guy's and Thomas' Hospital (GSTT), London in 2004. 4 This is consistent with a number of studies reporting reductions in MRSA transmission, bacteremia and colonization following introduction of universal chlorhexidine skin washes. [8] [9] [10] Introduction of heightened infection control measures also uncovered a hidden twoyear outbreak due to an ST239 clone (ST239-TW) which probably originated from Singapore and is one of five major ST239 clades (the Thai clade). 11 While transmission of ST22 and ST36 clones decreased following the introduction of decolonization with chlorhexidine on the GSTT ICU, the transmission of ST239-TW did not. 4, 8, [12] [13] [14] A C C E P T E D M A N U S C R I P T
We previously reported that ST239-TW had an increase in chlorhexidine MBC compared with non-TW MRSA isolates (ST22 and ST36), based on analysis of five skin isolates identified during the outbreak. 8 MRSA blood stream infection (BSI) isolates from the same outbreak were analyzed for their CHG (chlorhexidine digluconate) MIC in 2013, reportedly clustering into MICs groups of < 2 mg/l and ≥ 2 mg/l. 12 ST239-TWs isolated during that outbreak all carry the plasmid borne qacA gene, which encodes a major facilitator superfamily efflux-pump that expels quaternary ammonium compounds and biguanides such as chlorhexidine, and has been associated with biocide tolerance. Carriage of qacA currently represents the accepted explanation for the lack of clinical effect of chlorhexidine on Staphylococci. [15] [16] [17] However, small increases in staphylococcal MICs or MBCs have been reported elsewhere, for which a correlation with qacA/B carriage was found to be equivocal, or otherwise associated with a modest one dilution increase in MIC, but with no effect on the MBC. [18] [19] [20] [21] [22] Given that there is no internationally endorsed standard for assessing biocide MICs and MBCs, except for the CLSI guideline (biocide activity measurement) 21 and no epidemiological breakpoints for the resistance of the test organism (BSAC, EUCAST or CLSI), the significance of these increases is unclear; particularly since surface acting biocides are typically applied in much higher concentrations than their in vitro MIC or MBC. 23 were not able to set such breakpoints. 21 
A C C E P T E D M A N U S C R I P T
One potential alternative survival mechanism to antimicrobials in bacteria is that of evading topical biocide action by invading human epithelial cells and hiding in an intracellular location. Indeed, staphylococcal adhesion, invasion and persistence has been observed in multiple human cell types (by professional and non-professional phagocytosis) and has been demonstrated as a means of evading the host innate immunity, also fostering deeper tissue and systemic infections, in addition to being postulated as a mode of surviving antibiotic action. [28] [29] [30] [31] [32] [33] S. aureus adhesion and internalization to human endothelial and epithelial cells via binding to fibrinogen and fibronectin has been widely studied, [34] [35] [36] [37] [38] and has to be included when investigating bacterial invasion into host cells. The fact that blood stream infection (BSI) isolates of ST239-TW with moderate chlorhexidine susceptibilities can persist after topical decolonization and thus outlive other clones requires detailed examination. 4, 8, 13, 38 We therefore sought to investigate whether ST239-TW isolates present with a biocide evasion strategy, based on a dominant keratinocyte adhesion and internalization phenotype and if this a plausible alternative mechanism of decolonization tolerance over other MRSA clones.
METHODS

Bacterial strains and growth conditions
A representative collection of six ST36 (three qacA + and three qacA -), six ST22 (three qacA + and three qacA -) and six ST239-TW isolates (all qacA + ; no qacAstrain initially isolated) were selected from a previously published strain set of 136 MRSA bloodstream infection isolates (BSI), from GSTT ICU patients between 2001 and Tables S1-3) . 12 The strains were chosen based on Table S4 ).
(Supplementary Material
BSI strain characteristics are stated in the Supplementary Material (Tables S1-3).
S. aureus NCTC 10788, a standard strain for chemical disinfection testing, was obtained from Public Health England and used as a quality control strain in CHG susceptibility testing.
In vitro chlorhexidine digluconate susceptibility testing
MICs were determined using a modified Clinical and Laboratory Standard Institute (CLSI) micro-dilution method, 40 
Bacterial binding to human immobilized fibrinogen and fibronectin
The adherence assay was performed using 10 μg/ml human fibrinogen or fibronectin (Merck Chemicals Ltd, UK). Aliquots of 100 µL stationary or exponential phase bacterial cultures were added to protein coated wells and incubated for 2 hours at 37°C. Bound bacteria were fixed with 25% formaldehyde and then stained with 0.1% crystal violet. Absorbance was measured at 570 nm (SpectraMax 190 Absorbance Microplate Reader, Molecular Devices) and readings corrected for background measurement with a bacteria-free control. S. aureus 8325-4 (fibronectin binding) or S. aureus Newman (fibrinogen binding) were included as binding controls. 42
Cell culture adhesion and internalization assay
A C C E P T E D M A N U S C R I P T
HaCaT cell line maintenance: The immortalized human keratinocyte cell line (HaCaT) was maintained at 37°C (5% CO 2 atmospheric pressure) in T75 or T175 flasks with DMEM medium (Lonza Ltd., Belgium), supplemented with 10% foetal calf serum (FCS) (First Link Ltd., UK) and 1% penicillin-streptomycin, 50 IU/ml (Life Technologies Inc., UK).
Combined bacterial adhesion and invasion assay
Bacterial adhesion and invasion of human epithelial cells was assayed as previously described 34, 37, 43 with the following modifications: Briefly, HaCaT cells (4.5 x 10 4 cells/ml) were seeded onto circular glass coverslips (13 mm diameter, VWR 632-0150) in 24-well tissue culture plates containing DMEM/10% FCS and 1% penicillinstreptomycin and grown to 80-90% confluency. Bacterial cultures were grown at 37°C in Brain Heart Infusion (BHI) broth to stationary phase, centrifuged, washed and re-suspended in DMEM/10% FCS without antibiotics. A 1 x 10 6 CFU/ml bacterial aliquot was added to each well of confluent HaCaT cells, incubated for 90 minutes at 37°C (5% CO 2 ), after which cells were carefully washed three times with PBS to remove non-adherend bacteria. The bacterial input CFU was checked for accuracy by serial dilution and plating onto BHI agar and colony counting after overnight incubation. For the combined adhesion and internalization assays, 0.5% trypsin (Worthington Biochemical Corp.) was added for 10 minutes at 37°C, to detach cells, and then neutralized with 1 ml DMEM/10% FCS. Cell suspensions were centrifuged (SIGMA 1-14 Microfuge, SciQuip Ltd.) at 14.800 rpm for 20 minutes and the mixed HaCaT/bacteria pellet resuspended in de-ionized water for 30 minutes to lyse the eukaryotic cells. Released bacteria were enumerated after overnight growth at 37°C on BHI agar to establish the proportion of both bound and internalized bacteria combined as CFU/ml.
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Bacterial invasion assay: The internalization assays were performed as described for the combined adhesion and uptake assay, only that after the 90 minute coincubation of cells and bacteria and the three PBS washes, extracellular adhered and non-adhered bacteria were killed by adding 50 µg/ml lysostaphin in DMEM/10% FCS for 1 hour at 37°C. Externally killed bacteria were washed off using PBS.
Detachment of HaCaT cells from the coverslip, cell lysis and bacterial enumeration of internalized bacteria was performed as described above. The HaCat cell viability, when incubated with 50 μg/ml lysostaphin for 1 hour and also the bacterial killing efficiency with 50 μg/ml lysostaphin was confirmed using the non-toxic alamarBlue ®
assay (Supplementary Material Figures S3 and S4).
Bacterial adhesion assay: Bacterial adhesion was calculated by subtracting CFUs/ml obtained from the internalization assay from CFUs/ml obtained from the combined adhesion and internalization assay. The final percentage of adhesion and uptake was calculated in relation to the total CFU input for each bacterial strain.
Chlorhexidine (CHG) killing efficiency
The combined adhesion and internalization assay was performed as described above, to test for superficial CHG efficacy on a keratinocyte-MRSA co-culture. No Before further processing, the samples were placed into 3% (v/v) glutaraldehyde in 0.1M cacodylate buffer (pH 7.3) and incubated for 24 hours. Finally, the samples were dehydrated for 10 minutes each in 20, 50, 70 and 90% ethanol, followed by 30 minutes incubation in 100% ethanol and a final drying step using hexamethyldisilazane. The samples were mounted onto stubs with a conducting carbon cement applied between, coated with gold and the images assessed with an FEI Quanta 3D FEG scanning electron microscope.
Statistical methods
All experiments were performed on six ST36, six ST22 and six ST239-TW isolates, where each isolate was tested in triplicates on at least two independent occasions and the results shown as the average derived from all strains per clonal group.
Statistical analysis was performed using GraphPad Prism 6.0 software. The two tailed non-parametric t test (Mann-Whitney ranked sum test) was applied to find differences between ST239-TW to ST22 and ST36 and the control strains, as well as qacA + and qacAstrains (MICs). Minimum statistical significance was set to P < 0.05.
RESULTS
Chlorhexidine (CHG) MICs
A C C E P T E D M A N U S C R I P T
Six qacA + ST239-TW, three qacA + and three qacA -ST36 and ST22 MRSA BSI isolates with comparable low MICs (Supplementary Material Table S4 ) were randomly selected from an initial 136 isolate cohort 12 and multiple replicate CHG testing performed to verify their initially established MICs (Table 1 ). Re-testing showed only minor differences in the clones' CHG susceptibilities compared to 2013 (Supplementary Material Table S4 ). The highest change in MIC was found for the ST22 clones, showing an increase of 45% compared to 2013. MICs of qacA + and qacA -ST36 and ST22 clones (1.75 mg/l ± 0.05 vs 1.47 mg/l ± 0.08, P = 0.29) were similar. The fact that all ST239-TW isolates from the initial cohort were qacA + needs to be noted. These results confirm the 2013 established low MICs and imply that qacA carriage alone cannot explain the in vivo chlorhexidine survival of ST239-TW at the intensive care unit (ICU) of Guy's and Thomas' Hospital. So, we investigated cell adhesion and uptake as an additional explanation for their survival under topically applied chlorhexidine pressure in a clinical setting.
Protein binding assay
Binding of MRSA clones to fibrinogen and fibronectin at stationary and exponential growth phases was first investigated (Figure 1 ). In general, protein binding was either equal or higher at stationary than at exponential bacterial growth phase. There were however clear differences between protein binding of the clonal groups in each growth phase. ST239-TW binding to both fibrinogen (OD570nm absorption: stationary 0.192; exponential 0.165) and fibronectin (stationary 0.350; exponential 0.172) was significantly higher than for ST22, ST36 and the control strains (P < 0.001) at exponential and stationary growth phases, with the exception of ST36 at exponential growth (fibronectin 0.077, P = 0.195; fibrinogen 0.089, 0.175, P = 0.211).
A C C E P T E D M A N U S C R I P T Adhesion to and internalization into human keratinocytes
Adherence and internalization of MRSA clones was assessed in vitro using an immortalized keratinocyte cell line (HaCaT) (Figure 2) . Here, only the adhesion and invasion propensities between the three clones was investigated, and not their survival or persistence, to provide preliminary data for further CHG effectiveness The percentage of inoculated ST239-TW, then binding to HaCaT cells (16.39%) was significantly greater than for ST22 (9.44%; P = 0.0021) and ST36 (4.73%; P < 0.0001). Also, with 0.41%, a greater proportion of inoculated ST239-TW bacteria internalized into keratinocytes than ST22 (0.22%; P = 0.0126) and ST36 (0.09%; P < 0.0001).
Chlorhexidine (CHG) efficacy on co-adhered and internalized MRSA to keratinocytes
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CHG at 6 mg/l, which is more than twice the MIC of all tested MRSA clones (Table 1) Figure S2 ). CHG treatment, of infected (bound and internalized bacteria) monolayers showed about a three-fold greater recovery of ST239-TW (12.79% survival; P < 0.001) compared with ST22 (3.18%) and ST36 (4.57%), but all three clinical clones were less likely to be killed by CHG than the control strains S. aureus Newman and S. aureus 8325-4 (< 0.7%; P < 0.0001) ( Table 2 ).
DISCUSSION
The widespread use of biocides for decolonization has become an important infection control intervention to decrease transmission of nosocomial pathogens, but has also raised concerns about the development of bacterial biocide tolerance. 13, 16, 44, 45 Here we show evidence that bacterial uptake into skin cells together with extracellular adherence can protect some MRSA clones against biocide action. This provides a putative mechanism whereby ST239-TW was able to resist chlorhexidine when introduced on the ICU of GSTT, in the absence of a measurable difference in MIC. Although it had previously been suggested that qacA and B carriage confers chlorhexidine tolerance, [15] [16] [17] our results can only partially support this. However, any effects of subtle increases of CHG MIC on ST239-TW internalized and adhered to keratinocytes were not evaluated and further, no distinction between qacA + and qacAisolates was possible. An alternative mechanism suggested by our data is that ST239-TW has a selective advantage compared to ST22 and ST36 clones during topical chlorhexidine treatment due to its Staphylococcal adhesion, invasion and persistence has been observed in multiple human cell types and has been postulated as a means of evading the host innate immunity and antibiotic action, leading to either recurrent or chronic infections. [28] [29] [30] [31] [32] However, the preliminary findings presented here support an additional hypothesis that by invading and adhering to skin cells, S. aureus (ST239-TW) is also protected against the important infection control intervention of chlorhexidine decolonization in healthcare settings. Binding to fibrinogen and fibronectin are key steps in staphylococcal adhesion and invasion, and thus are of relevance in disease pathogenesis. [34] [35] [36] [37] We found that compared with ST22 and ST36, ST239-TW showed increased binding to fibrinogen and fibronectin, and increased adherence and internalization into keratinocyte monolayers. This supports the clinical phenomenon of in vivo chlorhexidine survival. However, we must note that common experimental investigations for S. aureus and eukaryotic cell interactions in vitro perform co-incubation for around one hour, 34, 37 ,43 which does not fully represent a long-term clinical exposure to MRSA, but certainly allows for the identification of differences between MRSA clones, whilst minimizing cell apoptotic side effects. 43, 47 The previous finding that some ST239 clones exhibit increased colonization potential to human nasal epithelial cells due to carriage of sasX, a mobile genetic elementencoded gene 48 also carried by ST239-TW 49 but not tested in this study, provides
A C C E P T E D M A N U S C R I P T
supporting evidence that host cell linked CHG survival, as also shown elsewhere 28-31 is an important virulence mechanism of this clone.
Persistent skin colonization during antiseptic decolonization is a concern not only for patients on ICUs. It could enable colonization of catheters leading to bacteremia 50 and colonization of healthcare workers' hands facilitating transmission to other patients. 14 Chlorhexidine is used extensively in hospitals for skin cleansing prior to invasive procedures and to remove antimicrobial resistant bacteria to prevent transmission or infection. [51] [52] [53] However, skin traumas which are often present in ICU patients due to surgery, intubation or intravenous catheter insertion, allow the exposure of extracellular matrix proteins on the epithelial surface, thus presenting excellent initial binding conditions for MRSA isolates. Indeed, the ST239-TW MRSA strains tested in this study showed elevated survival to CHG in vitro when adhered and internalized to keratinocyte monolayers. Similarly Lehar et al. showed that a minority of MRSA can actually survive in macrophages, even under antibiotic pressure, and retain their ability to establish infections. 32 Recent clinical studies have observed high rates of qacA carriage by Staphylococci including those isolated from healthcare workers, and in some studies that has been linked with extensive chlorhexidine use. 54, 55 Connecting multi-drug efflux pumps such as the one encoded by qacA to a decreased staphylococcal susceptibility against cationic antiseptic agents (e.g. chlorhexidine) seems to be reasonable, but remains controversial. 15, 16, 20, 21, 45 In contrast with previous findings, showing a two-to four-fold increase in chlorhexidine MBC of five tested qacA + ST239-TW skin isolates, 13 no conclusion could be drawn from our ST239-TW BSI isolates, since all strains M A N U S C R I P T specifically selected, had a moderate MIC below 2 mg/l, despite being qacA + . It is possible that the elevated MBC phenotype from skin isolates analyzed shortly after the outbreak at GSTT may have been lost after storage. Conversely, serial passaging of six ST239-TW isolates whilst exposed to sub-inhibitory CHG concentrations in vitro did not increase their MICs (Supplementary Material Figure   S1 ). Consistent with other studies, we showed that biocide activity is not, or only partially affected by the presence of a S. aureus efflux pump. 18,19,21 Nevertheless, we cannot exclude that qacA carriage plays a role in the in vivo ST239-TW chlorhexidine tolerance phenotype. 13, 50 It remains possible that unknown factors are required to demonstrate the chlorhexidine resistance phenotype of qacA + strains in the laboratory.
The findings presented here provide evidence to support the hypothesis that the clinical chlorhexidine phenotype (in vivo decolonization tolerance) of some MRSA clones may be due to adhesion and intracellular invasion of keratinocytes. However, further experiments will be required, with prolonged chlorhexidine exposure and antibiotic co-treatment in primary cell cultures and skin models 56, 57 to examine the effects of keratinocyte antimicrobial peptides, 58 and to extend our findings by identifying the bacterial factors involved in protection against chlorhexidine and additionally investigate the consequences of intracellular survival on the host cells.
Also, the relative importance of adhesion versus internalization and whether this phenomenon is associated with other clones with a similar in vivo phenotype needs to be established. Although our findings need further investigation, we feel that there is compelling evidence that the host cell invasion mechanism employed by MRSA 
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